About: VASCULAR ENDOTHELIAL GROWTH FACTOR AS PROGNOSTIC FACTOR IN RENAL CELL CARCINOMA

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: VASCULAR ENDOTHELIAL GROWTH FACTOR AS PROGNOSTIC FACTOR IN RENAL CELL CARCINOMA Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article by JAN JACOBSEN et al published January 2000 in Journal of Urology

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) wüsseschaftlicher Artikel, wo im Johr 2000 veröffentlicht worden isch (gsw) наукова стаття, опублікована в січні 2000 (uk) article scientifique publié en 2000 (fr) im Januar 2000 veröffentlichter wissenschaftlicher Artikel (de) article by JAN JACOBSEN et al published January 2000 in Journal of Urology (en)
publication date	wds:Q58352402-8DB7D4B1-6138-49CC-A8DA-48E10B9D2C23
publication date	2000-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q58352402-43865675-553E-4C91-9987-7A4BAB064517
language of work or name	English
author name string	wds:Q58352402-81342CD8-48BC-4D66-8C7A-CFCDEB3293DA wds:Q58352402-B8149429-44DB-4DAF-A34F-80206FB7E62C
author name string	JAN JACOBSEN TORGNY RASMUSON
rdfs:label	VASCULAR ENDOTHELIAL GROWTH FACTOR AS PROGNOSTIC FACTOR IN RENAL CELL CARCINOMA (en) VASCULAR ENDOTHELIAL GROWTH FACTOR AS PROGNOSTIC FACTOR IN RENAL CELL CARCINOMA (nl)
skos:prefLabel	VASCULAR ENDOTHELIAL GROWTH FACTOR AS PROGNOSTIC FACTOR IN RENAL CELL CARCINOMA (en) VASCULAR ENDOTHELIAL GROWTH FACTOR AS PROGNOSTIC FACTOR IN RENAL CELL CARCINOMA (nl)
name	VASCULAR ENDOTHELIAL GROWTH FACTOR AS PROGNOSTIC FACTOR IN RENAL CELL CARCINOMA (en) VASCULAR ENDOTHELIAL GROWTH FACTOR AS PROGNOSTIC FACTOR IN RENAL CELL CARCINOMA (nl)
author	wds:Q58352402-9825C16D-782E-4E29-9EBF-0EF0816433F1 wds:Q58352402-D7981B18-B082-4782-94F4-7187373F3A53
author	Börje Ljungberg Kjell Grankvist
title	wds:Q58352402-1CA1C9E3-D943-44A3-AAA7-028D82AE2DDF
title	VASCULAR ENDOTHELIAL GROWTH FACTOR AS PROGNOSTIC FACTOR IN RENAL CELL CARCINOMA (en)
page(s)	wds:Q58352402-2642DEEA-DCFD-4215-8CD9-D14C8DB90225
page(s)	343-347
instance of	wds:Q58352402-164FD846-A4DF-4056-AF81-4C58A4B340B2
instance of	scholarly article
main subject	wds:Q58352402-614AB3EE-538B-4C4C-91E6-C8B9DA7D2860 wds:Q58352402-D2871483-47A1-447D-9EA4-72D83C7731C7
main subject	endothelium renal cell carcinoma
published in	wds:Q58352402-D3C32A72-BAD3-474F-8C6F-B46F2D985BD8
published in	Journal of Urology
issue	wds:Q58352402-0CC8F8FA-8BC8-46C3-8E42-A72BB689A2BF
volume	wds:Q58352402-DDA4A8C2-C0EA-40B6-8C13-B2A79901CD81
issue	1
volume	163
DOI	wds:Q58352402-DBC9E5E1-DE73-40F9-BCA9-F075D203E4EA
DOI	http://dx.doi.org/10.1016/S0022-5347(05)68049-4
DOI	10.1016/S0022-5347(05)68049-4
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q58352402
is cites work of	Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma What can molecular pathology contribute to the management of renal cell carcinoma? Expression of vascular endothelial growth factor in renal cell carcinoma is correlated with cancer advancement Analysis of various potential prognostic markers and survival data in clear cell renal cell carcinoma Therapeutic options to target angiogenesis in human malignancies VEGF blocking therapy in the treatment of cancer Levels of circulating CD45(dim)CD34(+)VEGFR2(+) progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma Everolimus for the treatment of advanced renal cell carcinoma Circulating angiogenic growth factor levels in mice bearing human tumors using Luminex Multiplex technology Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma Levels of angiogenesis and expression of angiogenesis-related genes are prognostic for organ-specific metastasis of renal cell carcinoma Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy Decreased expression of CHIP leads to increased angiogenesis via VEGF-VEGFR2 pathway and poor prognosis in human renal cell carcinoma Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes Maximal COX-2 immunostaining and clinical response to celecoxib and interferon alpha therapy in metastatic renal cell carcinoma Signalling pathways in prostate carcinogenesis: potentials for molecular-targeted therapy Decreased selenium-binding protein 1 mRNA expression is associated with poor prognosis in renal cell carcinoma Diagnostic and prognostic role of preoperative circulating CA 15-3, CA 125, and beta-2 microglobulin in renal cell carcinoma. Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma. Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma. Interferon Alfa-2b Three Times Daily and Thalidomide in the Treatment of Metastatic Renal Cell Carcinoma Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy? Prognostic biomarkers in renal cell carcinoma Expression of a flt-4 (VEGFR3) splicing variant in primary human prostate tumors. VEGF D and flt-4t(Delta773-1081) overexpression is diagnostic for sentinel lymph node metastasis Evaluation of everolimus in renal cell cancer Prognostic models and algorithms in renal cell carcinoma New agents for the treatment of renal cell carcinoma Colon cancer angiogenesis and antiangiogenic therapy Clinical implications of angiogenesis in cancers Nephron-sparing surgery for renal cell carcinoma--long-term results Molecular biomarkers for advanced renal cell carcinoma: implications for prognosis and therapy. The current status of tailor-made medicine with molecular biomarkers for patients with clear cell renal cell carcinoma Expression of vascular endothelial growth factor in renal cell carcinoma and the relation to angiogenesis and p53 protein expression Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma Potential use of circulating endothelial cells as a biomarker of renal cell carcinoma Circulating biomarkers for vascular endothelial growth factor inhibitors in renal cell carcinoma The free beta-subunit of human chorionic gonadotropin as a prognostic factor in renal cell carcinoma Intermittent hypoxia increases kidney tumor vascularization in a murine model of sleep apnea. Effects of PTK787/ZK222584, a Tyrosine Kinase Inhibitor, on the Growth of a Poorly Differentiated Thyroid Carcinoma: An Animal Study Angiogenesis and other markers for prediction of survival in metastatic renal cell carcinoma Inhibition of renal cell carcinoma angiogenesis and growth by antisense oligonucleotides targeting vascular endothelial growth factor Bevacizumab for the treatment of advanced non-small-cell lung cancer Quantitative RT-PCR assay for MUC3 and VEGF mRNA in renal clear cell carcinoma: relationship with nuclear grade and prognosis. Current staging of renal cell carcinoma Targeted therapy in renal cancer Renal cell cancer: overview of the current therapeutic landscape. Preoperative high levels of serum vascular endothelial growth factor are a prognostic marker for poor outcome after surgical treatment of renal cell carcinoma. Endostatin gene therapy stimulates upregulation of ICAM-1 and VCAM-1 in a metastatic renal cell carcinoma model Role of cytoreductive nephrectomy in renal cell carcinoma. The role of cytoreductive nephrectomy for renal cell carcinoma in the era of targeted therapy Reference intervals for circulating angiogenic cytokines. Serum level and immunohistochemical expression of vascular endothelial growth factor for the prediction of postoperative recurrence in renal cell carcinoma [Is tumour expression of VEGF associated with venous invasion and survival in pT3 renal cell carcinoma?]
is cites work of	wds:Q31126032-91C5DCBD-9DC0-4CB3-8F4F-4C183912023A

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software